Fanconi anemia (FA) is caused by defective genes for DNA-repair leading to bone marrow failure, developmental abnormalities and increased cancer risk. Using genome-wide genetic approaches, researchers systematically screened for the loss of an additional gene that could rescue the disease — and found it. The corresponding protein turned out to be a potential target that could be therapeutically exploited for FA.